![Schematic representation of the main *cis* elements in the MMTV promoter and their occupancy in nucleosomes assembled *in vitro* (upper panel) and in intact cells after hormone induction (lower panel).\
The positions covered by the main population of histone octamers are indicated by the grey ovals. The HREs, the NF1 binding site and the TATA box are indicated. The numbers refer to the distance in nucleotides from the transcription start site. The hormone receptor (PR) dimers are depicted in yellow and the NF1 dimer by green circles.](nrs07008.f1){#fig1}

![Hypothetical model for the initial steps of MMTV promoter induction.\
Progestins bind to cytoplasmic PR/ER complexes, and activate the Src/Ras/Erk pathway, leading to nuclear accumulation of activated Erk. Most of PR is nuclear and complexed to chaperones (Hsps). Upon binding of progestins, PR homodimers dissociate from chaperones and a fraction of PR is phosphorylated by pErk, which also phosphorylates Msk1. A "PR -activated complex" composed of pPR/pErk/pMsk1 is formed.](nrs07008.f2){#fig2}

![Hypothetical model for the role of "PR activated complex" in chromatin.\
Upper Panel: (1) An HP1γ-containing complex is bound to the promoter in the absence of hormone; (2) PR-activated complex binds BAF, but not PBAF; (3) PR-activated complex is recruited to the nucleosome B upon hormone induction, followed by H3 phosphoacetylation. The repressive complex is displaced from the promoter; (4) Recruitment of the BAF complex to the nucleosome B is stabilized by PCAF-dependent H3K14 acetylation, enabling ATP-dependent H2A/H2B displacement (and/or histone variants incorporation); (5) This metastable opening facilitates NF1 binding, generating a stable platform for the assembly of further PR molecules, BAF, coactivators and the basal transcriptional machinery, including RNA polymerase II. Lower Panel: T47D-MTVL cells were untreated (0) or treated for 5 min with 10 nM R-5020 and subjected to ChIP assays with the indicated specific antibodies. A schematic representation of the ChIPs described in (Vicent et al., 2006a) and (Vicent et al., 2009) is shown.](nrs07008.f3){#fig3}

Introduction
============

The promoter of the mouse mammary tumor virus (MMTV) provirus is a well-characterized example of transcriptional control by steroid hormones in which the chromatin organization plays an important role \[[@r43]\]. The provirus integrated in the host cell chromatin is virtually silent in the absence of hormones, but responds with rapid transcriptional activation to the addition of either glucocorticoids or progestins. The receptors for these hormones bind to a cluster of HREs in the MMTV promoter and facilitate the interaction of ubiquitous transcription factors including Nuclear Factor 1 (NF1) \[[@r21]\] and the octamer transcription factor, Oct1/OTF1 \[[@r11]\] with their target sites located between the HREs and the TATA box. This results in a synergistic activation of transcription by the hormone receptors and NF1 (for a review see \[[@r5]\]). How synergism between PR and NF1 occurs is a question that has attracted considerable attention, but the mechanism is not simply cooperative DNA binding of the various proteins to the MMTV promoter DNA \[[@r12]\].

Chromatin organization and factor binding
=========================================

The LTR region of MMTV is organized into positioned nucleosomes \[[@r43]\] and hormone induction leads to the appearance of a DNase I-hypersensitive region over the promoter chromatin \[[@r63]\], suggesting an influence of hormone induction on the chromatin organization of the promoter ([Figure 1](#fig1){ref-type="fig"}). A role for nucleosome phasing in MMTV regulation has been postulated based on studies with breast cancer cell lines carrying a single copy of MMTV reporter stably integrated and on *in vitro* nucleosome assembly studies \[[@r51]\]. Though the exact positioning of nucleosome over the MMTV promoter has been debated \[[@r25]\], a dominant nucleosome phase in breast cancer cells precludes binding of NF1, but permits steroid hormone receptors (SHRs) to recognize one properly oriented HRE within the HRE cluster \[[@r51]\] ([Figure 1](#fig1){ref-type="fig"}). The different affinities of SHRs and NF1 for nucleosomally-organized target sites can be reproduced *in vitro* \[[@r22]; [@r40]\] and reflect the different ways in which the two proteins recognize their cognate DNA sequences \[[@r4]\]. SHRs only contact a narrow region of the HRE DNA double helix and can therefore bind if this section is exposed, while NF1 embraces the complete circumference of the helix and thus cannot interact with target sites within nucleosomes. When both SHRs and NF1 are added simultaneously to isolated MMTV mononucleosomes, the receptors bind to the accessible HREs, but NF1 is unable to recognize its target sites ([Figure 1](#fig1){ref-type="fig"}) \[[@r40]\], suggesting that additional components are required for simultaneous factor binding as detected in intact cells by genomic footprinting analysis following hormone treatment \[[@r51]\].

When introduced in *Saccharomyces cerevisiae* engineered to express GR or PR, the MMTV promoter is organized into positioned nucleosomes, is silent in the absence of hormone, and responds poorly to expression of NFI or to a NFI-VP16 fusion, but can be induced by hormone treatment \[[@r17]\]. Deletion of the HREs disrupts nucleosome positioning and makes the promoter responsive to NFI-VP16, suggesting that the HRE region would repress access to the NFI site by positioning a nucleosome \[[@r14]\]. The nucleosomal organization of the MMTV promoter *in vitro* is similar in yeast and animal cells, implying that the DNA sequence contains conformational or topological information which determines nucleosome positioning \[[@r41]\] and thus modulates the accessibility of transcription factors to *cis*-acting elements.

Hormone induction was believed to result in a displacement of the nucleosome over the promoter, thus allowing free access of NF1 to its binding site and transcriptional activation \[[@r43]\]. However, genomic footprinting of the chromosomal MMTV promoter shows that hormone induction does not lead to displacement, but rather to a rearrangement of nucleosomes, which is necessary for simultaneous binding of receptors, NFI and OTF1 \[[@r51]\]. Thus, contrary to the situation in the test tube, the presence of a positioned nucleosome *in vivo* is not an obstacle, but rather a prerequisite for simultaneous factor binding and optimal induction of the MMTV promoter ([Figure 1](#fig1){ref-type="fig"}) \[[@r51]\]. This is strongly supported by the observation that nucleosome depletion in yeast, while enhancing the accessibility of the MMTV promoter for hormone receptors and NF1, eliminates the functional synergism between these two factors \[[@r16]\]. Moreover, in a cell-free system, synergistic binding of receptors and NF1 to the MMTV promoters depends on its previous assembly into minichromosomes with positioned nucleosomes and on preincubation in the presence of ATP \[[@r21]\].

FRET experiments and footprints
===============================

Fluorescence photobleaching experiments in living cells containing a cluster of 200 MMTV promoters in tandem have provided direct evidence that the hormone-occupied GR undergoes rapid exchange between chromatin and the nucleoplasmic compartment with a half-life of less than a minute \[[@r33]\]. This rapid exchange has also been reported for the ERα \[[@r47]; [@r48]\]. In agreement with the difficulties in visualizing a footprint of GR on the MMTV promoter *in vivo*, this has led to the formulation of a "hit-and-run" model of receptor action \[[@r44]\]. However, following dexamethasone treatment of hepatic cells, such footprints have been reported on the GREs of the tyrosine aminotransferase enhancer \[[@r6]; [@r24]\]. Similarly, after progestin addition to breast cancer cells, DNase I and DMS footprints are observed on a single copy chromosomal MMTV promoter \[[@r51]\]. Moreover, following incubation of MMTV minichromosomes with purified PR in *Drosophila* embryo extracts, clear DNase I footprints are detected over the HREs \[[@r21]\]. These results demonstrate that a significant fraction of target promoters must be occupied by the receptors during the time of treatment with the footprinting agents, DMS or DNase I. How these findings can be reconciled with the very rapid exchange of GR-GFP observed *in vivo* remains to be elucidated. One possibility is that the majority of the GR binding events observed in the MMTV cluster *in vivo* are non-productive and do not lead to stable complexes containing receptors and NF1. Non-productive does not imply irrelevant. Possibly, many of these weak interactions are needed to form a stable complex of PR and NF1. Indeed, in the absence of NF1, it is exceedingly difficult to generate a receptor footprint on MMTV chromatin *in vitro*. This can only be achieved after addition of very high concentrations of receptor that push the equilibrium to the DNA bound state \[[@r21]\]. Nevertheless, even in the absence of NF1, receptor concentrations which do not generate a footprint can activate chromatin transcription to some extent, indicating that an interaction is taking place. That this short-lived interaction could correspond to the rapid exchange observed *in vivo* is suggested by the observation that after hormone induction only a small proportion of the MMTV clusters exhibit the phenomenon of chromatin decondensation, indicative of active transcription \[[@r39]\].

Hormone-dependent chromatin remodeling
======================================

Role of histone H1
------------------

The nature of the hormone-induced nucleosomal change that permits simultaneous binding of transcription factors to the MMTV promoter remains obscure. Depletion of histone H1 from the MMTV promoter could be a possibility \[[@r7]\] and a role for histone H1 phosphorylation in modulating MMTV activation has been postulated \[[@r31]\]. However, the MMTV promoter is regulated in budding yeast, which lacks linker histones \[[@r17]\], and also in minichromosomes assembled in the absence of histone H1 \[[@r21]\]. Incorporation of H1 into MMTV minichromosomes increases nucleosome spacing and reduces access of general transcription factors to the promoter, thus inhibiting basal transcription \[[@r29]\]. However, transcription activation by PR and NF1 is enhanced in H1 containing minichromosomes \[[@r29]\]. This unexpected effect is due to a more homogeneous positioning of nucleosomes in the presence of H1 \[[@r57]\] and, as a consequence, a better binding of PR \[[@r29]; [@r57]\] and a higher proportion of promoters participating in transcription \[[@r29]\]. Moreover, in the presence of bound PR in an extract from *Drosophila* embryos, H1 is phosphorylated and subsequently removed from the promoter upon transcription initiation \[[@r29]\].

Histone acetylation
-------------------

Additional possibilities for chromatin remodeling are recruitment by the receptors of chromatin remodeling activities, either ATP-dependent, such as the SWI/SNF complex \[[@r20]\], or ATP-independent, such as histone acetyltransferases (HATs) \[[@r30]\]. This latter possibility has received considerable attention following the discovery that several steroid receptor coactivators exhibit HAT activity, including members of the SRC-1 family, P/CAF and p300/CBP \[[@r10]\].

The role of histone acetylation in hormone induction of the MMTV promoter in not clear. High doses of histone deacetylase inhibitors, butyrate or TSA, lead to intense hyperacetylation of core histones and inhibit hormone induction \[[@r3]; [@r8]\] without altering nucleosome positioning \[[@r9]\]. However, low doses of the inhibitors activate the MMTV promoter in the absence of hormone and generate a DNAse I-hypersensitive site similar to that observed following hormone treatment \[[@r3]\]. Derepressing concentrations of the inhibitors of histone deacetylases enhance hormone-activated transcription, and thus the extent of hormonal induction is not affected \[[@r3]\]. Similar results are obtained with these inhibitors in the cell-free transcription assay with MMTV minichromosomes, suggesting that inhibitor-sensitive acetylation is not involved in mediating the synergism between receptors and NF1. More recently, a role for histone deacetylase 1 (HDAC1) has been proposed for MMTV activation \[[@r42]\]. HDAC1, generally considered as a corepressor, acts as a coactivator of the glucocorticoid receptor (GR) and its histone deacetylase activity is regulated by a p300-dependent acetylation \[[@r42]\]. The mechanism of this effect remains unclear.

ATP-dependent remodeling
------------------------

The SWI/SNF complex, or other ATP-dependent chromatin remodeling factors, could destabilize the interaction between the DNA double helix and the histone octamer and thus facilitate access to otherwise masked *cis* elements. Hormone-induced chromatin remodeling might also facilitate the assembly of the transcription initiation complex (TIC) on the TATA box, and/or contribute to efficient transcription elongation through downstream nucleosomes.

There is evidence for a requirement of the SWI/SNF complex in glucocorticoid gene regulation in yeast \[[@r62]\] and in animal cells \[[@r38]\], and hSWI/SNF seems to be required for chromatin remodeling initiated by glucocorticoids \[[@r26]\]. The situation appears to be different for progestins, which act through the same HREs of the MMTV promoter \[[@r26]\]. We have reproduced the synergism between SHR and NF1 in a cell-free system driven by MMTV minichromosomes assembled in extracts from *Drosophila* embryos \[[@r21]\]. These minichromosomes exhibit nucleosomes positioned in the same way as in cultured cells and the NF1 site in the promoter is not accessible \[[@r53]\]. Addition of hormone-activated GR or PR leads to ATP-dependent remodeling of these minichromosomes, as demonstrated by topoisomer analysis \[[@r21]\], and to simultaneous binding of receptors and NF1. This activity can be partly reproduced with purified MMTV minichromosomes with recombinant dISWI, but not with purified dCHRAC or ySWI/SNF complex \[[@r21]\]. Moreover, incubation of the minichromosomes in the *Drosophila* extract in the presence of receptors and NF1 leads to recruitment of dISWI, and dNURF301, two subunits of the NURF complex \[[@r27]\]. Thus, in the *Drosophila* embryo extract, PR recruits NURF to the MMTV promoter chromatin, and NURF remodels the minichromosomes in an ATP-dependent fashion.

In mammalian cells with a single MMTV promoter integrated in chromatin we have recently found the hormone-induced recruitment of both Brg1- and ISWI-containing complexes to the promoter \[[@r56]; [@r58]\]. Moreover, in experiments with MMTV mononucleosomes assembled *in vitro*, PR is able to recruit purified yeast Swi/Snf to the promoter, where it catalyzes the ATP-dependent displacement of H2A/H2B dimers \[[@r58]\]. Though we cannot formally exclude the possibility of a replacement of the H2A/H2B dimers by dimers containing histone variants, our results strongly suggest that the activated MMTV nucleosome with bound SHRs and NF1 is a H3/H4 tetramer particle. This assumption is further supported by our previous findings showing that MMTV promoter sequences assembled *in vitro* on H3/H4 tetramers, adopt similar positions as on a histone octamer, but in contrast with sequences assembled on the octamer, are able to bind SHRs and NF1 \[[@r46]\].

There are two human SWI/SNF-like complexes and both contain ATPase subunits similar to yeast Swi2/Snf2, hBRM (human Brahma) or BRG1 (Brahma-Related Gene 1), as well as a series of other subunits, some of which differ in various cell types \[[@r60]\]. The hSWI/SNF-α complex, also called BAF (BRG1/hBRM-associated factor), contains either hBRM or BRG1 as the central ATPase subunit and is an orthologue of the yeast SWI/SNF. The hSWI/SNF-β complex, also called PBAF (Polybromo-associated BAF), contains only hBRM and is an orthologue to the yeast RSC complex \[[@r37]\]. The BAF and PBAF complexes share many subunits, but also contain subtype-specific subunits: BAF250 and hBRM are only found in BAF, whereas BAF180 and BAF 200 are only found in PBAF \[[@r37]; [@r61]\].

In breast cancer cells that contain BAF and PBAF, we have recently found that BAF is essential during the activation of MMTV and other endogenous progesterone-induced genes. BAF is recruited via an interaction between PR and the BAF57 subunit of the complex and is anchored by H3K14ac, generated by PCAF, suggesting a mechanism for the cooperation between two types of chromatin remodeling activities. The recruited BAF catalyzes the ATP-dependent displacement of histones H2A/H2B required for NF1 to gain access to the promoter site. Thus, synergism between the two transcription factors PR and NF1 is mediated by the cooperation between two chromatin-remodeling machines, BAF and PCAF \[[@r59]\].

Link between protein kinases and transcriptional control
--------------------------------------------------------

In addition to their transcriptional effect, steroid hormones also crosstalk to kinase signaling pathways, and this crosstalk is essential for the proliferative response of breast cancer cells to estrogens \[[@r35]\] and progesterone \[[@r36]\].

What could be the connection between the rapid hormonal activation of cytoplasmic signaling cascades and the events taking place at the MMTV promoter? We have investigated the function of Erk activation by progesterone, which is mediated via an interaction between PR and ERα ([Figure 2](#fig2){ref-type="fig"} and \[[@r2]\]). We observed that progestin activation of the MMTV promoter can be blocked by inhibiting Erk activation either with antiestrogens, with small molecular inhibitors (PD 98059), with dominant negative kinase mutant, or with RNAi against Erk \[[@r55]\]. As Erk phosphorylated PR at ser294 in response to progesterone, it was possible that the transcriptional inhibition of MMTV induction was due to a lack of PR phosphorylation. However, a similar inhibition of MMTV induction was observed when the activation of Msk1 was prevented by small molecular inhibitors (H89), a dominant negative mutant of Msk, or down-regulation of Msk1 with an specific RNAi \[[@r55]\]. Unexpectedly, after 5 minutes of hormone treatment, we detected a ternary complex of phosphorylated PR and activated Erk and Msk1 ([Figure 2](#fig2){ref-type="fig"}), which is selectively recruited to the MMTV promoter nucleosome containing the HREs ([Figure 3](#fig3){ref-type="fig"}) \[[@r55]\]. Concomitant with the recruitment of the ternary complex, histone H3 becomes phosphorylated at serine 10 and acetylated at lysine 14, only on the nucleosome containing the HREs and not on adjacent nucleosomes ([Figure 3](#fig3){ref-type="fig"}) \[[@r55]\]. Blocking H3 phosphoacetylation precludes displacement of a repressive complex containing HP1γ and recruitment of BAF, preventing H2A/H2B displacement and promoter activation.

Microarray analysis of the progesterone response in breast cancer cells (Ballare et al., manuscript in preparation), showed that about 25% of the hormonally-regulated genes are sensitive to the inhibition of Erk activation. This shows that the behavior of the MMTV promoter does not represent a rare exception, but also suggests that other signaling pathways are involved in mediating progesterone action. We know that the PI3K/Akt pathway is involved in the regulation of stromal cell proliferation in the endometrium \[[@r52]\], and also in the proliferative response of breast cancer cells to estrogens \[[@r15]\]. There is also evidence that the cAMP/PKA pathway is implicated in estrogen action (\[[@r1]; [@r18]\]), and that the JAK/STAT5 plays an important role in glucocorticoid and progesterone effects in mammary gland (\[[@r13]; [@r49]; [@r50]\]). It remains to be established whether the crosstalk of the SHR with these different pathways acts merely by regulating the phosphorylation of key transcription factors and coregulators, or whether, as in the case of the Erk pathway, modifications of structural components of the chromatin also play an important role.

Conclusions
===========

The results summarized in this review contribute to a better understanding of the molecular mechanisms of promoter activation by progesterone. During activation of the MMTV promoter, the chromatin constitutes a key component essential for regulation of transcription by allowing synergism between the nuclear receptors and NF-1, causing full activation of the promoter.

The linker histone H1, known as a repressive component of chromatin needed for condensation, increases MMTV transcription by improving the positioning of nucleosomes. PR interacts with an exposed HRE on the surface of a nucleosome and initiates chromatin remodeling as a prerequisite for the subsequent steps of gene activation.

The nucleosomal DNA sequence, as part of chromatin, contains the information required to direct the outcome of the subsequent remodeling event. The SWI/SNF complex, depending on the DNA sequence, can displace histones H2A and H2B or slide the nucleosome toward one end of the DNA fragment. Thus, the "final outcome" in each case is completely different, depending on structural features of the underlying DNA, which confer the differential response to SWI/SNF action and should be further developed.

The results with the MMTV promoter underline the significance of incorporating a precise knowledge of the structure of native DNA sequences in chromatin. Evidence for the positive contributions of chromatin structure and dynamics to the process of gene regulation continues to accumulate at an increasing pace. A classical example is a situation in which a positioned nucleosome brings in close proximity *cis*-regulatory elements located some 200 bp apart and in this way facilitates the interaction between DNA-bound factors. There are several examples of this type of regulation (for a recent report see \[[@r64]\]), and one case involves an interaction of the estrogen receptor with the transcription factor NF1 \[[@r45]\].

A particularly illustrative example of the significance of chromatin is the regulation of the Human Immunodeficiency Virus type 1 (HIV-1), the etiologic agent of AIDS. Recent advances have indicated that HIV-1 encoded proteins interact with chromatin-remodeling complexes and histone-modifying enzymes, implying that chromatin remodeling plays an important role in the HIV-1 life cycle \[[@r28]; [@r32]\]. Nucleosomes are positioned on the HIV-1 LTR and act as barriers to transcription. Following cellular activation, these nucleosomes are modified and repositioned, allowing for activation of viral gene expression \[[@r23]; [@r54]\].

Another example where chromatin has been shown to be essential is the gene regulation of the rat albumin gene enhancer. In its active state, in liver nuclei, the enhancer is organized into a nuclease-accessible array of three positioned nucleosome-like particles N1, N2, and N3, with bound transcription factors \[[@r34]\]. The N1 nucleosome-like particle at the albumin enhancer is positioned over the FoxA binding sites and is DNase I-hypersensitive in hepatic cells. In contrast, in non-liver tissues, where the FoxA sites are not occupied, nucleosome-like particles are not precisely positioned over the enhancer, and the enhancer is not hypersensitive \[[@r34]\]. It has been observed that FoxA and GATA-4 bound their sites in compacted chromatin and opened the local nucleosomal domain in the absence of ATP-dependent enzymes \[[@r19]\].

These are just a few examples of the intricacies that the chromatin organization of promoters and regulatory regions impose on gene regulation. This complexity is partly due to the fact that one of the key events during cell differentiation in complex organisms is the progressive chromatin-mediated silencing of genes that are not required in a particular cell lineage and the proper chromatin organization of those genes that will be needed at some later stage of differentiation or in response to external signals. Understanding this differential chromatin organization of particular genome regions is the main challenge for epigenetic research in the coming years.
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